Engineered Virus-Like Particle to Deliver CRISPR-Cas9 Ribonucleoprotein in Vivo with Saturated Efficacy and Minimal Off-Target EffectsZihua Jiang, Hua Lu, Martin Chan,Bang Wang,Zongli ZhengMOLECULAR THERAPY(2024)引用 0|浏览2AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要